| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| May 1, 2026 | ±12.0% | +0.6% | over-priced |
| October 30, 2025 | ±6.3% | +1.7% | over-priced |
| August 1, 2025 | ±6.3% | -3.0% | over-priced |
| May 2, 2025 | ±4.7% | +2.9% | over-priced |
| November 1, 2024 | ±2.9% | +0.3% | over-priced |
| August 2, 2024 | ±6.3% | -3.7% | over-priced |
| May 3, 2024 | ±3.8% | +2.6% | over-priced |
| November 3, 2023 | ±2.9% | +2.1% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $2.53 | $1.3B | $399M |
| Q4 FY2025 | $1.62 | $1.1B | $257M |
| Q3 FY2025 | $0.75 | $769M | $120M |
| Q2 FY2025 | $0.49 | $652M | $78M |
Teradyne, Inc. Common Stock (TER) reports in 93 days, with the next report estimated for September 14, 2026. Across the last 8 reports, options priced an average ±5.7% earnings move while the stock actually moved 2.1% on average — the market has systematically over-priced TER's earnings risk. Fundamentals into the print: EPS up 314.8% year-over-year, revenue up 87.0%. QuantLogix's live 5-factor engine currently reads TER as a strong buy at 70/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →